Role of Cardiac Sub-Structure (CSS) Dose on Overall Survival (OS) in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients (Pts) Treated with Concurrent Definitive Chemoradiotherapy (CDCRT)

被引：0
|
作者：
Dulling, T. J. [1 ]
Allen, A. [2 ]
Edrich, O. [3 ]
Lee, D. H. [4 ]
Money, D. [5 ]
Eichelberger, G. [6 ]
Kumar, A. [6 ]
Cruz-Chamorro, R. J. [7 ]
El Naqa, I. [8 ]
Bryant, J. M. [9 ]
Keit, E. [10 ]
Feygelman, V. [7 ]
Dudas, D. [11 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] Univ S Florida, Sch Med, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Machine Learning, Tampa, FL USA
[4] Morsani Coll Med, Div Cardiovasc Med, Tampa, FL USA
[5] Morsani Coll Med, Dept Internal Med, Tampa, FL USA
[6] Duke Univ Med Ctr, Dept Radiat Oncol, Durham, NC USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Machine Learning, Tampa, FL USA
[9] Univ S Florida, Tampa, FL USA
[10] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[11] Czech Tech Univ, Fac Nucl Sci & Phys Engn, Prague, Czech Republic
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2032
引用
收藏
页码：E16 / E17
页数：2
相关论文
共 50 条
  • [21] CONCURRENT CHEMORADIOTHERAPY (CONCRT) USING CISPLATIN-VINORELBINE IN LOCALLY ADVANCED (LA) NON-SMALL CELL LUNG CANCER (NSCLC)
    Charalambous, Haris
    Katodritis, Nicos
    Vomvas, Demetrios
    Maimaris, Michalis
    Decatris, Marios
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1154 - S1154
  • [22] Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
    Yan, Meng
    Zhang, Zhen
    Tian, Jia
    Yu, Jiaqi
    Dekker, Andre
    De Ruysscher, Dirk
    Wee, Leonard
    Zhao, Lujun
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [23] Overall Survival (OS) of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) After Negative Invasive Mediastinal Staging
    Bourdages-Pageau, E.
    Vieira, A.
    Labbe, C.
    Figueroa, P. Ugalde
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2233 - S2234
  • [24] The influence of cardiac and pulmonary comorbidities on overall survival (OS) among stage III non-small cell lung cancer (NSCLC) patients treated with definitive radiotherapy (RT)
    Correa, C. R.
    Wang, L.
    Zhao, L.
    Hayman, J.
    Kalemkerian, G.
    Cease, K.
    Brenner, D.
    Kong, F. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S428 - S429
  • [25] Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Bergamino, Milana
    Rullan, Antonio J.
    Saigi, Maria
    Peiro, Inmaculada
    Montanya, Eduard
    Palmero, Ramon
    Carlos Ruffinelli, Jose
    Navarro, Arturo
    Dolores Arnaiz, Maria
    Brao, Isabel
    Aso, Samantha
    Padrones, Susana
    Cardenal, Felipe
    Nadal, Ernest
    BMC CANCER, 2019, 19 (1)
  • [26] Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
    Erkan Topkan
    Cem Parlak
    Savas Topuk
    Berrin Pehlivan
    BMC Cancer, 12
  • [27] Identifying the Optimal Radiation Dose in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Treated With Definitive Radiation Therapy Without Concurrent Chemotherapy
    Oro, F.
    Sonnick, M.
    Wu, A. J.
    Shi, W.
    Zhang, Z.
    Gelblum, D.
    Paik, P.
    Yorke, E. D.
    Rosenzweig, K.
    Chaft, J.
    Rimner, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S89 - S89
  • [28] Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Milana Bergamino
    Antonio J. Rullan
    Maria Saigí
    Inmaculada Peiró
    Eduard Montanya
    Ramón Palmero
    José Carlos Ruffinelli
    Arturo Navarro
    María Dolores Arnaiz
    Isabel Brao
    Samantha Aso
    Susana Padrones
    Felipe Cardenal
    Ernest Nadal
    BMC Cancer, 19
  • [29] Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
    Topkan, Erkan
    Parlak, Cem
    Topuk, Savas
    Pehlivan, Berrin
    BMC CANCER, 2012, 12
  • [30] Higher Radiation Dose to Immune Cells is a Negative Prognostic Factor in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
    Friedes, C.
    Yegya-Raman, N.
    Iocolano, M.
    Lee, S. H.
    Su, W.
    Duan, L.
    Li, B.
    Doucette, A.
    Cohen, R.
    Aggarwal, C.
    Levin, W.
    Cengel, K.
    Teo, K.
    Langer, C.
    Xiao, Y.
    Bradley, J.
    Feigenberg, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S576 - S576
12345